 |
The Journal of Neuroscience, September 13, 2006, 26(37):9471-9481; doi:10.1523/JNEUROSCI.2838-06.2006
Previous Article | Next Article 
Cellular/Molecular
The Transcriptional Activator Hypoxia Inducible Factor 2 (HIF-2/EPAS-1) Regulates the Oxygen-Dependent Expression of Erythropoietin in Cortical Astrocytes
Juan C. Chavez,1,2
Oxana Baranova,1
Janice Lin,1 and
Paola Pichiule3
1Burke Medical Research Institute, White Plains, New York 10605, 2Department of Neurology and Neuroscience, Weil Medical College of Cornell University, New York, New York 10021, and 3Department of Pediatrics, Morgan Stanley Childrens Hospital, Columbia University, New York, New York 10032
Correspondence should be addressed to Dr. Juan C. Chavez, Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY 10605. Email: jchavez{at}burke.org or Email: jcc2005{at}med.cornell.edu
In the ischemic or hypoxic brain, astrocytes appear to be one of the main sources of erythropoietin (EPO). In this study, we investigated the differential contribution of hypoxia inducible factor (HIF) isoforms to the regulation of hypoxic EPO expression in cultured astrocytes. In addition, using an in vitro model of oxygen-glucose deprivation (OGD), we studied the role of HIF-1 and HIF-2 in the generation of paracrine protective signals by astrocytes that modulate the survival of neurons exposed to OGD. Expression of HIF-1 or HIF-2 was abrogated by infecting astrocytes with lentiviral particles encoding small interference RNA specific for HIF-1 or HIF-2 (siHIF-1 or siHIF-2 ). Astrocytes infected with siHIF-1 showed abrogated hypoxic induction of vascular endothelial growth factor (VEGF) and lactate dehydrogenase (LDH) but normal EPO induction. In contrast, reduction of HIF-2 expression by siHIF-2 led to a drastic decrease of EPO hypoxic expression, but it did not affect LDH or VEGF upregulation. To further test whether HIF-2 is sufficient to drive EPO upregulation, we expressed oxygen-insensitive mutant forms of HIF-1 (mtHIF-1 ) (P402A/P577A) and HIF-2 (mtHIF-2 ) (P405A/P530A). Expression of mtHIF-2 but not mtHIF-1 in normoxic astrocytes resulted in a significant upregulation of EPO mRNA and protein. Accordingly, HIF-2 but not HIF-1 was found to be associated with the EPO hypoxia-response element by a chromatin immunoprecipitation assay. Interestingly, conditioned medium from astrocytes challenged by sublethal OGD improved neuronal survival to OGD; however, this effect was abolished during the downregulation of astrocytic HIF-2 using siHIF-2 . These results indicate that HIF-2 mediates the transcriptional activation of EPO expression in astrocytes, and this pathway may promote astrocytic paracrine-dependent neuronal survival during ischemia.
Key words: hypoxia; transcription; gene expression; EPO; astrocytes; HIF
Received June 8, 2006;
revised July 31, 2006;
accepted Aug. 1, 2006.
Correspondence should be addressed to Dr. Juan C. Chavez, Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY 10605. Email: jchavez{at}burke.org or Email: jcc2005{at}med.cornell.edu
This article has been cited by other articles:

|
 |

|
 |
 
T. Yamashita, K. Ohneda, M. Nagano, C. Miyoshi, N. Kaneko, Y. Miwa, M. Yamamoto, O. Ohneda, and Y. Fujii-Kuriyama
Hypoxia-inducible Transcription Factor-2{alpha} in Endothelial Cells Regulates Tumor Neovascularization through Activation of Ephrin A1
J. Biol. Chem.,
July 4, 2008;
283(27):
18926 - 18936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Lange, J. C. Chavez, J. T. Pinto, G. Coppola, C.-W. Sun, T. M. Townes, D. H. Geschwind, and R. R. Ratan
ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo
J. Exp. Med.,
May 12, 2008;
205(5):
1227 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vangeison, D. Carr, H. J. Federoff, and D. A. Rempe
The Good, the Bad, and the Cell Type-Specific Roles of Hypoxia Inducible Factor-1{alpha} in Neurons and Astrocytes
J. Neurosci.,
February 20, 2008;
28(8):
1988 - 1993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pichiule, J. C. Chavez, A. M. Schmidt, and S. J. Vannucci
Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia
J. Biol. Chem.,
December 14, 2007;
282(50):
36330 - 36340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin
Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes
Endocrinology,
October 1, 2007;
148(10):
4745 - 4753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Percy, M. Sanchez, S. Swierczek, M. F. McMullin, M. P. Mojica-Henshaw, M. U. Muckenthaler, J. T. Prchal, and M. W. Hentze
Is congenital secondary erythrocytosis/polycythemia caused by activating mutations within the HIF-2{alpha} iron-responsive element?
Blood,
October 1, 2007;
110(7):
2776 - 2777.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Baranova, L. F. Miranda, P. Pichiule, I. Dragatsis, R. S. Johnson, and J. C. Chavez
Neuron-Specific Inactivation of the Hypoxia Inducible Factor 1{alpha} Increases Brain Injury in a Mouse Model of Transient Focal Cerebral Ischemia
J. Neurosci.,
June 6, 2007;
27(23):
6320 - 6332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Rempe, K. M. Lelli, G. Vangeison, R. S. Johnson, and H. J. Federoff
In Cultured Astrocytes, p53 and MDM2 Do Not Alter Hypoxia-inducible Factor-1{alpha} Function Regardless of the Presence of DNA Damage
J. Biol. Chem.,
June 1, 2007;
282(22):
16187 - 16201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Milosevic, M. Maisel, F. Wegner, J. Leuchtenberger, R. H. Wenger, M. Gerlach, A. Storch, and J. Schwarz
Lack of Hypoxia-Inducible Factor-1{alpha} Impairs Midbrain Neural Precursor Cells Involving Vascular Endothelial Growth Factor Signaling
J. Neurosci.,
January 10, 2007;
27(2):
412 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|